Início › Câncer de Próstata › Distrito de Columbia › Washington
Ensaios clínicos de Câncer de Próstata em Washington, DC
38 estudos para Câncer de Próstata estão buscando participantes em locais em Washington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecrutandoFase 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collection of Blood From Patients With Prostate Cancer
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecrutandoFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Precision-Based Genomics in Prostate Cancer
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Collection of Blood From Patients With Cancer
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RecrutandoFase 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RecrutandoFase 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecrutandoFase 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecrutandoFase 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · a 11 mi de distância
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Men at High Genetic Risk for Prostate Cancer
RecrutandoEstudo observacional
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
RecrutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Recrutando
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
RecrutandoFase 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecrutandoFase 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · a 7 mi de distância
FOG-001 in Locally Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
RecrutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecrutandoFase 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RecrutandoFase 1
- Maryland Oncology Hematology, Silver Spring · a 7 mi de distância
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- National Institutes of Health Clinical Center, Bethesda · a 7 mi de distância
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
RecrutandoFase 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Recrutando
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
RecrutandoFase 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
RecrutandoFase 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · a 7 mi de distância
- Walter Reed National Military Medical Center, Bethesda · a 7 mi de distância
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecrutandoEstudo observacional
- Massive Bio SYNERGY-AI site, Silver Spring · a 7 mi de distância
- Massive Bio SYNERGY-AI site, Bethesda · a 7 mi de distância
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecrutandoFase 3
- George Washington University Medical Center, Washington D.C.
Ensaios de Câncer de Próstata em outras cidades
- New York City, NY103 estudos
- Houston, TX76 estudos
- Los Angeles, CA61 estudos
- Boston, MA59 estudos
- St. Louis, MO46 estudos
- Chicago, IL45 estudos
- San Francisco, CA45 estudos
- Philadelphia, PA44 estudos
- Baltimore, MD43 estudos
- Nashville, TN43 estudos
- Seattle, WA42 estudos
- Dallas, TX36 estudos
Outros estudos em Washington
- Câncer (todos os tipos)58 estudos
- Câncer de Pulmão de Não Pequenas Células55 estudos
- Câncer de Mama46 estudos
- Câncer Metastático43 estudos
- Câncer de Pulmão41 estudos
- Obesidade33 estudos
- Câncer Colorretal29 estudos
- Doença Cardiovascular28 estudos
- Câncer de Bexiga26 estudos
- Leucemia Mieloide Aguda24 estudos
- Câncer de Ovário23 estudos
- Linfoma23 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.